Antibody-mediated rejection: analyzing the risk, proposing solutions

Affiliation

• ¹ 1 Nephrology Department, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain. 2 Instituto Carlos III, Red de Investigació en Enfermedades Renales (REDinREN), Madrid, Spain. 3 Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 4 Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada. 5 Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada. 6 Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada. 7 Nephrology Department, Hospital Universitari Vall D ´Hebron, Barcelona, Spain. 8 Immunology Department, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain. 9 Heart Transplant Program, Cardiology Department, Complejo Universitario de A Coruña, Spain. 10 Pneumology Department, Hospital Universitari Vall D ´Hebron, Barcelona, Spain. 11 Department of Nephrology, Hospital Universitari Vall D ´Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain. 12 Nephrology and Dialysis Division, Medical University Vienna, Austria. 13 Address correspondence to: Manuel Arias, M.D., Nephrology Department, Edificio 2 de Noviembre, planta 1a, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.